Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis

PURPOSE: Immune checkpoint inhibitor (ICI) therapy often is suspended because of immune-mediated diarrhea and colitis (IMDC). We examined the rate of and risk factors for IMDC recurrence after ICI resumption. METHODS: This retrospective multicenter study examined patients who resumed ICI therapy aft...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Oncol
Main Authors: Abu-Sbeih, Hamzah, Ali, Faisal S., Naqash, Abdul Rafeh, Owen, Dwight H., Patel, Sandipkumar, Otterson, Gregory A., Kendra, Kari, Ricciuti, Biagio, Chiari, Rita, De Giglio, Andrea, Sleiman, Joseph, Funchain, Pauline, Wills, Beatriz, Zhang, Jiajia, Naidoo, Jarushka, Philpott, Jessica, Gao, Jianjun, Subudhi, Sumit K., Wang, Yinghong
Format: Artigo
Language:Inglês
Published: American Society of Clinical Oncology 2019
Subjects:
Original Reports
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6800279/
https://ncbi.nlm.nih.gov/pubmed/31163011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.00320
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items